Naeve Gregory S. 4
4 · BELLICUM PHARMACEUTICALS, INC · Filed Aug 23, 2017
Insider Transaction Report
Form 4
Naeve Gregory S.
Sr. VP, Chief Business Officer
Transactions
- Award
Common Stock
2017-08-21+15,000→ 15,000 total - Award
Employee Stock Option (right to buy)
2017-08-21+130,000→ 130,000 totalExercise: $7.63Exp: 2027-08-20→ Common Stock (130,000 underlying)
Footnotes (2)
- [F1]Represents grant of restricted stock units payable solely in common stock that vest in four equal annual installments on each of the one, two, three and four year anniversaries of August 21, 2017.
- [F2]25% of the shares subject to the stock option vest and become exercisable on August 21, 2018, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter.